Proteomics

Core Concept

Proteomics is the large-scale study of the proteome — the complete set of proteins expressed by a cell, tissue, or organism, including their abundances, modifications, and interactions. Because protein levels are governed by translation, turnover, and post-translational modification (not just mRNA), the proteome must be measured directly. The core method is mass spectrometry (MS): proteins are digested into peptides, ionized, and separated by their mass-to-charge ratio (m/z); selected peptides are fragmented (MS/MS), and the fragment spectra are matched against a database to identify the parent proteins and quantify their abundance. Proteomics measures protein identity, amount, and modification — the closest large-scale readout to the functional output of the genome.

Key Components

Protein extraction and digestion

• Proteins are extracted, denatured, and cleaved with a specific protease (usually trypsin, which cuts after lysine/arginine) into predictable peptides.

Liquid chromatography (LC)

• Peptides are separated by hydrophobicity before entering the mass spectrometer, reducing complexity and increasing coverage.

Mass spectrometry (MS and MS/MS)

• An ion source ionizes peptides (electrospray); the first analyzer measures m/z (MS1); selected precursor ions are fragmented (collision-induced dissociation) and their fragments measured (MS2), generating a "fingerprint" of each peptide.

Database search and quantification

• Fragment spectra are matched to theoretical spectra from a protein database (e.g., UniProt) to identify peptides/proteins; abundance is estimated from peptide ion intensities (label-free, or with isobaric tags such as TMT/iTRAQ, or stable isotope labeling).

Post-translational modification (PTM) analysis

• Mass shifts in fragment spectra reveal modifications (phosphorylation +80 Da, ubiquitination, acetylation, etc.).

Mechanism

1. Extract and digest. Proteins are isolated and cut with trypsin into peptides.
2. Separate. Peptides are resolved by liquid chromatography.
3. Ionize and measure. Peptides are ionized; MS1 records each peptide's m/z.
4. Fragment. Selected peptides are fragmented; MS2 records the fragment-ion spectrum.
5. Identify. Software matches MS2 spectra to a database, naming the peptides and their parent proteins.
6. Quantify. Peptide intensities (or reporter tags) yield relative/absolute protein abundance; PTMs are read from mass shifts.

Energy and Directionality

Mass spectrometry is a physical separation, not an enzymatic reaction: gas-phase ions are accelerated and steered by electric/magnetic fields, and the "signal" is the m/z of each ion. Ionization and fragmentation require input energy (electrospray voltage; collision energy in MS/MS) to break peptide bonds at predictable positions. The information flows directionally — intact peptide mass (MS1) → fragment masses (MS2) → matched sequence — and the biological conclusion (which protein, how much, what modification) is inferred from that physical readout.

Experimental Evidence

• What it measures: protein identity, abundance, and post-translational modifications across a sample (the proteome).
• Principle: protease digestion → LC separation → MS1/MS2 mass-to-charge measurement → database matching.
• Input: protein lysate (cells/tissue); Output: lists of identified proteins with (relative) abundances and detected PTMs.
• What it can prove: which proteins are actually present and in what relative amounts (unlike mRNA); that a modification (e.g., phosphorylation) occurs at a specific site; protein-complex composition (via affinity purification + MS); differential protein abundance between conditions.
• What it cannot prove: protein activity or functional state directly (a protein can be abundant but inactive); spatial localization; dynamic transient interactions without specialized approaches; and it may miss low-abundance or poorly ionized proteins (incomplete coverage).
• Controls/quality steps: technical and biological replicates; spike-in standards for absolute quantification; false-discovery-rate (FDR) control in database matching (decoy database) to avoid mis-identifications; and validation by Western blot or targeted MS (e.g., SRM/PRM) of key hits.
• Common mistakes: equating protein abundance with activity; over-trusting single-peptide identifications; ignoring FDR; incomplete digestion affecting quantitation; and assuming mRNA and protein levels will agree.

Common confusions

• "Proteomics reads protein sequences like DNA sequencing" — MS identifies proteins by matching peptide masses/fragments to a database, not by base-by-base sequencing.
• "mRNA levels predict protein levels" — They correlate poorly in many cases; translation, turnover, and PTMs intervene.
• "The proteome is fixed by the genome" — One gene can yield many protein forms via splicing and PTMs; the proteome is dynamic and context-dependent.
• "Abundance = activity" — A protein can be present but inactive (needs PTM, binding partner, or correct localization).
• "MS sees every protein" — Low-abundance, hydrophobic, or poorly ionizing proteins are often missed (incomplete coverage).

Quick review

• Extract proteins → trypsin digest → LC → MS1 (m/z) → MS2 (fragments) → database match → identify/quantify/PTMs.
• Measures protein identity, abundance, and modifications — the functional layer.
• Protein ≠ mRNA, and abundance ≠ activity; validate key hits with Western/targeted MS.